Artwork

Content provided by Pacific Neuroscience Institute and Think Neuro. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pacific Neuroscience Institute and Think Neuro or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

46. Psilocybin for Major Depressive Disorder | Guest Podcast

29:39
 
Share
 

Manage episode 376227846 series 3488064
Content provided by Pacific Neuroscience Institute and Think Neuro. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pacific Neuroscience Institute and Think Neuro or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In a study published on August 31, 2023, in the Journal of the American Medical Association, psilocybin showed promise as a treatment for major depressive disorder (MDD).

JAMA Associate Editor Dr. Donald C. Goff, speaks with publication author Dr. Charles L. Raison, from the Usona Institute, about the study, as well as Dr. Rachel Yehuda from Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies.

Pacific Neuroscience Institute's director of Treatment & Research In Psychedelics Center, Dr. Keith Heinzerling and PNI director Dr. Daniel Kelly were a co-investigators in this study.

  continue reading

209 episodes

Artwork
iconShare
 
Manage episode 376227846 series 3488064
Content provided by Pacific Neuroscience Institute and Think Neuro. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pacific Neuroscience Institute and Think Neuro or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In a study published on August 31, 2023, in the Journal of the American Medical Association, psilocybin showed promise as a treatment for major depressive disorder (MDD).

JAMA Associate Editor Dr. Donald C. Goff, speaks with publication author Dr. Charles L. Raison, from the Usona Institute, about the study, as well as Dr. Rachel Yehuda from Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies.

Pacific Neuroscience Institute's director of Treatment & Research In Psychedelics Center, Dr. Keith Heinzerling and PNI director Dr. Daniel Kelly were a co-investigators in this study.

  continue reading

209 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide